Italian researches have demonstrated a better way of determining the aggressiveness of tumors in patients with advanced non-small cell lung cancer (NSCLC). In a study presented in the featured ...
A new research paper titled "Comparison of FDG-PET/CT and CT for evaluation of tumor response to nivolumab plus ipilimumab combination therapy and prognosis prediction in patients with unresectable ...
In a direct comparison, FDG-PET proved superior to MRI with arterial spin labelling (ASL) for diagnosing and differentiating various forms of dementia; however, there remains a need for the latter ...
FDG PET imaging measures glucose uptake in the brain. It has long served as a proxy for neuronal health—but is it? In the October 13 Science Translational Medicine, researchers led by Christian Haass ...
Paraneoplastic syndrome is a rare and poorly understood systemic manifestation of malignancy that can involve multiple organ systems. [1] Detection of the underlying malignancy is key to treatment.
OriCAR-017, a novel GPRC5D-targeting CAR-T, in patients with relapsed/refractory multiple myeloma: Long term follow-up results of phase 1 study (POLARIS). This is an ASCO Meeting Abstract from the ...
Gastric cancers accounted for 11,180 deaths in the U.S. alone in 2021, and almost two-thirds are diagnosed at an advanced stage. A recent study evaluated the efficacy of 18F-FDG PET/CT to determine ...
[18F]FDG-PET to identify pathological responses upon neoadjuvant immune checkpoint blockade in cutaneous squamous cell carcinoma. Successful management of Australian patients with locally advanced ...
A novel quantitative PET- and MRI-based imaging approach can objectively identify a recently recognized type of ...
FDG-PET/CT could be very helpful in calculating the risk of developing interval metastasis during neoadjuvant chemoradiotherapy for oesophageal cancer, and it could lead to other more appropriate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results